Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.
Canby-Hagino
Edith D
ED
Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA. canbyhagino@uthscsa.edu
Thompson
Ian M
IM
D000728:Androgens / Q000494:pharmacology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D018890:Chemoprevention; D004032:Diet; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D016021:Epidemiologic Studies; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation; D008297:Male; D011471:Prostatic Neoplasms / Q000503:physiopathology* / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D000728:Androgens; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D004791:Enzyme Inhibitors; D018120:Finasteride